NMPA Approval

Haemophilus Influenzae Type b Conjugate Vaccine

Approval Number

国药准字S20130006

Company成都生物制品研究所有限责任公司

Registration Date

March 1, 2023

Drug Information

Generic Name

b型流感嗜血杆菌结合疫苗

Dosage Form

注射剂

Strength

每瓶为0.5ml,每1次人用剂量为0.5ml,含纯化b型流感嗜血杆菌荚膜多糖应不低于10μg(共价结合约20μg的破伤风类毒素)。

Drug Type

生物制品

Registration Date

March 1, 2023

Company Information

Applicant Company

Company Name成都生物制品研究所有限责任公司

Company Address

成都市锦江区锦华路三段379号

Manufacturing Company

Company Name成都生物制品研究所有限责任公司

Company Address

成都市锦江区锦华路三段379号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

b型流感嗜血杆菌结合疫苗 - NMPA 批准文号 | MedPath